A No-Prophylaxis Platelet-Transfusion Strategy for Hematologic Cancers

  • Stanworth S
  • Estcourt L
  • Powter G
  • et al.
381Citations
Citations of this article
364Readers
Mendeley users who have this article in their library.

Abstract

BACKGROUND: The effectiveness of platelet transfusions to prevent bleeding in patients with hematologic cancers remains unclear. This trial assessed whether a policy of not giving prophylactic platelet transfusions was as effective and safe as a policy of providing prophylaxis. METHODS: We conducted this randomized, open-label, noninferiority trial at 14 centers in the United Kingdom and Australia. Patients were randomly assigned to receive, or not to receive, prophylactic platelet transfusions when morning platelet counts were less than 10×10 9 per liter. Eligible patients were persons 16 years of age or older who were receiving chemotherapy or undergoing stem-cell transplantation and who had or were expected to have thrombocytopenia. The primary end point was bleeding of World Health Organization (WHO) grade 2, 3, or 4 up to 30 days after randomization. RESULTS: A total of 600 patients (301 in the no-prophylaxis group and 299 in the prophylaxis group) underwent randomization between 2006 and 2011. Bleeding of WHO grade 2, 3, or 4 occurred in 151 of 300 patients (50%) in the no-prophylaxis group, as compared with 128 of 298 (43%) in the prophylaxis group (adjusted difference in proportions, 8.4 percentage points; 90% confidence interval, 1.7 to 15.2; P = 0.06 for noninferiority). Patients in the no-prophylaxis group had more days with bleeding and a shorter time to the first bleeding episode than did patients in the prophylaxis group. Platelet use was markedly reduced in the no-prophylaxis group. A prespecified subgroup analysis identified similar rates of bleeding in the two study groups among patients undergoing autologous stem-cell transplantation. CONCLUSIONS: The results of our study support the need for the continued use of prophylaxis with platelet transfusion and show the benefit of such prophylaxis for reducing bleeding, as compared with no prophylaxis. A significant number of patients had bleeding despite prophylaxis. (Funded by the National Health Service Blood and Transplant Research and Development Committee and the Australian Red Cross Blood Service; TOPPS Controlled-Trials.com number, ISRCTN08758735.) Copyright © 2013 Massachusetts Medical Society.

References Powered by Scopus

Trials to assess equivalence: The importance of rigorous methods

882Citations
N/AReaders
Get full text

Guidelines for the use of platelet transfusions

540Citations
N/AReaders
Get full text

Dose of prophylactic platelet transfusions and prevention of hemorrhage

539Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

4886Citations
N/AReaders
Get full text

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

4477Citations
N/AReaders
Get full text

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

2364Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Stanworth, S. J., Estcourt, L. J., Powter, G., Kahan, B. C., Dyer, C., Choo, L., … Murphy, M. F. (2013). A No-Prophylaxis Platelet-Transfusion Strategy for Hematologic Cancers. New England Journal of Medicine, 368(19), 1771–1780. https://doi.org/10.1056/nejmoa1212772

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 123

53%

Researcher 74

32%

Professor / Associate Prof. 26

11%

Lecturer / Post doc 9

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 218

86%

Agricultural and Biological Sciences 22

9%

Nursing and Health Professions 8

3%

Biochemistry, Genetics and Molecular Bi... 6

2%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
News Mentions: 1
Social Media
Shares, Likes & Comments: 95

Save time finding and organizing research with Mendeley

Sign up for free